arrow
C

Catello Vollono

università cattolica del sacro cuore
H指数:29
被引数:2,911

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study

瑞美吉泮在多次急性偏头痛发作中的有效性:一项真实世界、前瞻性、多中心研究

2026-10-270
PRE
Preliminary evidence of long‐term safety and effectiveness of anti‐ CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52‐week follow‐up retrospective study

初步证据表明抗<scp>CGRP</scp>药物在合并癫痫患者中预防偏头痛的长期安全性和有效性:一项为期52周的随访回顾性研究

2026-10-090
OAAI
Triple Preventive Therapy with OnabotulinumtoxinA, Fremanezumab, and Atogepant in Treatment-Resistant Chronic Migraine: A 52-Week Pilot Case Series (TRIPLE Cohort)

奥巴肉毒毒素A、夫瑞马尼单抗和阿托格普坦三联预防疗法在治疗抵抗性慢性偏头痛中的应用:一项为期52周的试点病例系列研究(TRIPLE队列)

2026-10-060
OAAI
Post-pipeline headache after flow-diverting stenting for unruptured intracranial aneurysms: clinical, radiological findings, and proposed scoring system

Pipeline 放置后颅内未破裂动脉瘤血流导向支架置入术后头痛:临床及影像学表现与评分系统构建

2026-05-270
OAAI
Awareness, attitudes, and clinical practices related to medication-overuse headache among italian pharmacists: results from a cross-sectional survey

意大利药剂师对药物过度使用性头痛的认知、态度及临床实践:一项横断面调查的结果

2026-04-280
OAAI
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)

拉米地坦在急性偏头痛治疗中的有效性与耐受性:一项真实世界、前瞻性、多中心研究(DART研究)

2025-12-210
OA
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
2025-02-011
PRE